Viatris (VTRS) Inventory (2019 - 2026)
Viatris (VTRS) posted Inventory of $3.9 billion for Q2 2026, little changed on a QoQ basis from $3.9 billion in Q1 2026, and down 7.76% year-over-year from $4.3 billion in Q2 2025.
Analysis
Viatris (VTRS) Inventory (2019 - 2026) Analysis & Trends
Viatris has reported Inventory for 8 years, with the latest figure at $3.9 billion in Q2 2026.
- On a quarterly basis, Inventory fell 7.76% year-over-year to $3.9 billion in Q2 2026; TTM through Jun 2026 was $3.9 billion, a 7.76% decrease from a year earlier, with the FY2025 full-year figure at $4.0 billion, up 3.76% from the prior year.
- Inventory was $3.9 billion for Q2 2026 at Viatris, roughly flat from $3.9 billion in the prior quarter.
- The five-year high for Inventory was $4.3 billion in Q2 2025, with the low at $3.4 billion in Q3 2022.
- Average Inventory over 5 years is $3.8 billion, with a median of $3.8 billion recorded in 2024.
- The sharpest annual moves came in 2022 and 2024: Inventory retreated 23.17% in 2022, then advanced 11.24% in 2024.
- Over 5 years, Inventory stood at $3.5 billion in 2022, then retreated by 1.41% to $3.5 billion in 2023, then rose by 11.08% to $3.9 billion in 2024, then advanced by 3.76% to $4.0 billion in 2025, then decreased by 1.65% to $3.9 billion in 2026.
- The last three Inventory figures came in at $3.9 billion (Q2 2026), $3.9 billion (Q1 2026), and $4.0 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.53 Bn | 38.88 Bn | 2.15 Bn | 3.22 Bn |
| 2 | Viatris | 19.14 Bn | 18.25 Bn | 1.46 Bn | 3.93 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | 850.02 Mn |
| 4 | Amneal Pharmaceuticals | 5.45 Bn | 5.33 Bn | 334.51 Mn | 677.95 Mn |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn | 1.60 Bn |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn | 226.55 Mn |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn | 143.15 Mn |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn | 179.91 Mn |
| 9 | Fennec Pharmaceuticals | 400.20 Mn | 358.95 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.79 Mn | 178.79 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.93 Bn |
| Mar 31, 2026 | 3.93 Bn |
| Dec 31, 2025 | 4.00 Bn |
| Sep 30, 2025 | 4.11 Bn |
| Jun 30, 2025 | 4.26 Bn |
| Mar 31, 2025 | 4.10 Bn |
| Dec 31, 2024 | 3.85 Bn |
| Sep 30, 2024 | 4.08 Bn |
| Jun 30, 2024 | 3.94 Bn |
| Mar 31, 2024 | 3.82 Bn |
| Dec 31, 2023 | 3.47 Bn |
| Sep 30, 2023 | 3.67 Bn |
| Jun 30, 2023 | 3.64 Bn |
| Mar 31, 2023 | 3.66 Bn |
| Dec 31, 2022 | 3.52 Bn |
| Sep 30, 2022 | 3.38 Bn |
| Jun 30, 2022 | 3.61 Bn |
| Mar 31, 2022 | 3.80 Bn |
| Dec 31, 2021 | 3.98 Bn |
| Sep 30, 2021 | 4.08 Bn |